Related Experiment Videos
What's new in peritoneal dialysis--an overview
1Department of Internal Medicine, University of Missouri Health Sciences Center, Columbia.
Kidney International. Supplement
|October 1, 1992
Summary
Continuous ambulatory peritoneal dialysis (CAPD) offers survival rates comparable to hemodialysis (HD). Improvements in CAPD technique and catheter care are enhancing patient outcomes and preserving kidney function.
Area of Science:
- Nephrology
- Renal Replacement Therapy
- Dialysis Technology
Background:
- Patient survival on continuous ambulatory peritoneal dialysis (CAPD) appears comparable to hemodialysis (HD) in similar patient groups.
- Technological advancements are improving the efficacy and safety of CAPD.
- Preservation of residual renal function is a key consideration in dialysis modality selection.
Purpose of the Study:
- To evaluate patient and technique survival rates for CAPD compared to HD.
- To identify factors contributing to improved outcomes in CAPD.
- To explore emerging therapies and their potential impact on CAPD effectiveness.
Main Methods:
- Comparative analysis of survival data between CAPD and HD patients.
- Review of recent advancements in CAPD devices, catheter design, and patient care protocols.
- Assessment of the long-term usability of the peritoneal membrane.
Main Results:
- CAPD patient survival rates are similar to those of HD.
- Decreasing peritonitis rates due to disconnect devices are improving CAPD technique survival.
- Enhanced catheter design and care are leading to better catheter survival.
- The peritoneal membrane remains viable for extended periods if peritonitis is managed.
- Residual renal function is better maintained with CAPD than HD.
Conclusions:
- CAPD is a viable renal replacement therapy with survival outcomes comparable to HD.
- Ongoing improvements in CAPD technology and management are enhancing its effectiveness.
- Preservation of residual renal function is a significant advantage of CAPD.